Stephen Morlock, Director at BioPharmX Corp (BPMX), bought 428,571 shares at $0.35 ($150K) on 2016-11-28, disclosed to the SEC on 2016-11-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| BPMX | BUY | 2016-01-15 | $18K | — | Filing → |
| BPMX | BUY | 2016-01-12 | $9K | — | Filing → |
| BPMX | BUY | 2016-01-11 | $7K | — | Filing → |